Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9
Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 4
Abstract
The online version of this article (doi:10.1208/s12248-015-9750-8) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Nageshwar R. Budha, Maya Leabman, Jin Y. Jin, D. Russell Wada, Amos Baruch, Kun Peng, Whittemore G. Tingley, John D. Davis
Keywords
Related Articles
- EP ID EP680972
- DOI 10.1208/s12248-015-9750-8
- Views 43
- Downloads 0
A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
The use of physiologically based pharmacokinetic (PBPK) models in the field of pediatric drug development has garnered much interest of late due to a recent Food and Drug Administration recommendation. The purpose of thi...
Permeability Comparison between Hepatocyte and Low Efflux MDCKII Cell Monolayer
Determination of passive permeability is not only important for predicting oral absorption and brain penetration, but also for accurately predicting hepatic clearance. High throughput (HT) measurement of passive permeabi...
Endocannabinoid signaling directs periimplantation events
An emerging concept in female reproduction is the role of endocannabinoids, a group of endogenously produced lipid mediators that bind to and activate cannabinoid receptors. Although adverse effects of cannabinoids in fe...
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
Empirical Bayes (“post hoc”) estimates (EBEs) of ηs provide modelers with diagnostics: the EBEs themselves, individual prediction (IPRED), and residual errors (individual weighted residual (IWRES)...
Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence
This summary workshop report highlights presentations and over-arching themes from an October 2011 workshop. Discussions focused on best practices in the application of biopharmaceutics in oral drug product development a...